Literature DB >> 28770238

Functional characterization of CD4 and CD8 T cell responses among human papillomavirus infected patients with ano-genital warts.

Manjula Singh1, Deepshi Thakral2, Narayan Rishi3, Hemanta Kumar Kar4, Dipendra Kumar Mitra2.   

Abstract

Ano-genital warts are considered one of the commonest and highly infectious sexually transmitted infections. These warts are primarily caused by the human papillomavirus (HPV) of the family Papillomaviridae, genus alpha-papillomavirus, species 10 and types 6 and 11. However the high recurrence rate of warts is a matter of serious concern to the patients and a challenge for the treating physician. The conventional treatment options are targeted only to the local site of warts. There is no systemic treatment modality as there is limited understanding of the disease immune-pathogenesis. The role of cell-mediated immunity in combating HPV infection is not clearly defined. Hence the present study is aimed at investigating the CD4+ T helper (Th1 and Th2) and CD8+ T cell responses among wart patients. In this study, we compared HPV6 and HPV11 antigen-specific T cell responses among venereal wart patients relative to healthy controls. Significant decrease in percent frequencies of IFN-γ producing CD4+ and CD8+ T cells were observed in HPV infected wart patients. On the other hand, the frequency of CD4+ T cells expressing IL-4 was significantly increased in these patients as compared to healthy controls. The observed functional skewing of HPV specific T cells from Th1 to Th2 response in patients indicated suppressed immunity against the HPV. Moreover, decrease in CD8 T cell function correlated with poor wart clearance. Our findings open future avenues for exploring potential immunomodulation strategies as an adjunct to standard treatment for better management of these patients and prevention of recurrence.

Entities:  

Keywords:  CD4 T cell; CD8 T cell; Human papillomavirus; IFN-γ; IL-4; Venereal warts

Year:  2017        PMID: 28770238      PMCID: PMC5510633          DOI: 10.1007/s13337-017-0382-8

Source DB:  PubMed          Journal:  Virusdisease        ISSN: 2347-3584


  42 in total

1.  A retrospective study of the pattern of sexually transmitted diseases during a ten-year period.

Authors:  Beena Narayanan
Journal:  Indian J Dermatol Venereol Leprol       Date:  2005 Sep-Oct       Impact factor: 2.545

Review 2.  Management of genital warts.

Authors:  Charles M Kodner; Soraya Nasraty
Journal:  Am Fam Physician       Date:  2004-12-15       Impact factor: 3.292

3.  Decreased Langerhans cell responses to IL-36γ: altered innate immunity in patients with recurrent respiratory papillomatosis.

Authors:  James DeVoti; Lynda Hatam; Alexandra Lucs; Ali Afzal; Allan Abramson; Bettie Steinberg; Vincent Bonagura
Journal:  Mol Med       Date:  2014-08-28       Impact factor: 6.354

4.  Systemic interferon alpha treatment of human condylomata acuminata.

Authors:  N Einhorn; P Ling; H Strander
Journal:  Acta Obstet Gynecol Scand       Date:  1983       Impact factor: 3.636

5.  The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha.

Authors:  P Barnard; N A McMillan
Journal:  Virology       Date:  1999-07-05       Impact factor: 3.616

Review 6.  Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.

Authors:  Eileen M Broomall; Sonya M Reynolds; Robert M Jacobson
Journal:  Postgrad Med       Date:  2010-03       Impact factor: 3.840

7.  Interferon for the therapy of condyloma acuminatum.

Authors:  S A Gall; C E Hughes; K Trofatter
Journal:  Am J Obstet Gynecol       Date:  1985-09-15       Impact factor: 8.661

8.  Expression of Foxp3+CD4+CD25+ regulatory T cells and Th1/Th2, Tc1/Tc2 profiles in the peripheral blood of patients with condyloma acuminatum.

Authors:  Y Xu; K-J Zhu; N Zhu; D-H Jiang; X-Z Chen; H Cheng
Journal:  Clin Exp Dermatol       Date:  2008-12-02       Impact factor: 3.470

9.  External genital warts: diagnosis, treatment, and prevention.

Authors:  D J Wiley; John Douglas; Karl Beutner; Tom Cox; Kenneth Fife; Anna-Barbara Moscicki; Lynne Fukumoto
Journal:  Clin Infect Dis       Date:  2002-10-15       Impact factor: 9.079

10.  Effect of HIV infection on the natural history of anal human papillomavirus infection.

Authors:  C W Critchlow; S E Hawes; J M Kuypers; G M Goldbaum; K K Holmes; C M Surawicz; N B Kiviat
Journal:  AIDS       Date:  1998-07-09       Impact factor: 4.177

View more
  4 in total

Review 1.  The Role of Inflammation in Anal Cancer.

Authors:  Amir Selimagic; Ada Dozic; Azra Husic-Selimovic; Nijaz Tucakovic; Amir Cehajic; Anela Subo; Azra Spahic; Nedim Vanis
Journal:  Diseases       Date:  2022-05-06

Review 2.  A Review on Inosine Pranobex Immunotherapy for Cervical HPV-Positive Patients.

Authors:  Stefan Miladinov Kovachev
Journal:  Infect Drug Resist       Date:  2021-06-02       Impact factor: 4.003

3.  Comparing the Efficacy of Chemical Cautery to Cryosurgery on CD4+ Status of HIV Patients with Condyloma Acuminata.

Authors:  Prasetyadi Mawardi; Bobby Febrianto; Danu Yuliarto; Tatar Sumandjar
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-10-07

4.  Dysregulation of the immune response affects the outcome of critical COVID-19 patients.

Authors:  Lin-Lin Wei; Wen-Jing Wang; De-Xi Chen; Bin Xu
Journal:  J Med Virol       Date:  2020-07-11       Impact factor: 20.693

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.